US equities |
META $630.56 ▲+0.00% MU $903.70 ▲+0.00% NVDA $216.00 ▲+0.00% TSLA $391.62 ▲+0.00% INTC $90.47 ▲+0.00% SPCX $146.90 ▲+0.00% AMD $531.28 ▲+0.00% SNDK $1,255.58 ▲+0.00%
FinancialContent

Latest News about Lophos Pharma

Recent news which mentions Lophos Pharma

Experts Discuss Botanical Psilocybin's Effect On Neurogenesis And More At Benzinga Cannabis Conference
Tickers CCC NEWS
Tags Markets Market News Events
From Benzinga
Meet The Company Developing Innovative Peyote-Based Treatments For Addiction, Anxiety, And Depression
Tags Lophos Pharma Benzinga Partner Content
From Benzinga
G2 Buys Peyote-Focused Psychedelics Company Lophos Pharma
Tags Greenridez 2/0 Acquisitions Corp Claire Stawnyczy Canalytica Corp
From Benzinga